US 9532989
Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines
granted A61KA61K31/497A61K31/519
Quick answer
US patent 9532989 (Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/497, A61K31/519, A61K45/06, A61P